| Schedule of intangible assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2022 |
|
|
Estimated |
|
|
|
|
|
|
|
|
|
|
|
Useful |
|
Gross |
|
|
|
|
|
|
|
|
Lives |
|
Carrying |
|
Accumulated |
|
Intangible |
($’s in thousands) |
|
(Years) |
|
Value |
|
Amortization |
|
Assets, Net |
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortizable intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Ceracade® |
|
|
3 |
|
$ |
300 |
|
$ |
(300) |
|
$ |
— |
Luxamend® |
|
|
3 |
|
|
50 |
|
|
(50) |
|
|
— |
Targadox® |
|
|
3 |
|
|
1,250 |
|
|
(1,250) |
|
|
— |
Ximino® |
|
|
7 |
|
|
7,134 |
|
|
(2,973) |
|
|
4,161 |
Exelderm® |
|
|
3 |
|
|
1,600 |
|
|
(1,600) |
|
|
— |
Accutane® |
|
|
5 |
|
|
4,727 |
|
|
(1,261) |
|
|
3,466 |
Amzeeq® |
|
|
9 |
|
|
15,162 |
|
|
(842) |
|
|
14,320 |
Zilxi® |
|
|
9 |
|
|
3,760 |
|
|
(209) |
|
|
3,551 |
|
|
|
|
|
|
33,983 |
|
|
(8,485) |
|
|
25,498 |
Non-amortizable intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Anti-itch product (1) |
|
|
3 |
|
|
3,942 |
|
|
— |
|
|
3,942 |
Total intangible assets |
|
|
|
|
$ |
37,925 |
|
$ |
(8,485) |
|
$ |
29,440 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
Estimated |
|
|
|
|
|
|
|
|
|
|
|
Useful |
|
Gross |
|
|
|
|
|
|
|
Lives |
|
Carrying |
|
Accumulated |
|
Intangible |
($’s in thousands) |
|
(Years) |
|
Value |
|
Amortization |
|
Assets, Net |
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortizable intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Ceracade® |
|
|
3 |
|
$ |
300 |
|
$ |
(300) |
|
$ |
— |
Luxamend® |
|
|
3 |
|
|
50 |
|
|
(50) |
|
|
— |
Targadox® |
|
|
3 |
|
|
1,250 |
|
|
(1,250) |
|
|
— |
Ximino® |
|
|
7 |
|
|
7,134 |
|
|
(2,463) |
|
|
4,671 |
Exelderm® |
|
|
3 |
|
|
1,600 |
|
|
(1,600) |
|
|
— |
Accutane® |
|
|
5 |
|
|
4,727 |
|
|
(788) |
|
|
3,939 |
|
|
|
|
|
|
15,061 |
|
|
(6,451) |
|
|
8,610 |
Non-amortizable intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Anti-itch product (1) |
|
|
3 |
|
|
3,942 |
|
|
— |
|
|
3,942 |
Total intangible assets |
|
|
|
|
$ |
19,003 |
|
$ |
(6,451) |
|
$ |
12,552 |
(1)The Company is transferring manufacturing to an existing contract manufacturer and upon validation will launch such product and commence amortizing.
|
| Schedule of future amortization of intangible assets |
|
|
|
|
|
|
Total |
($’s in thousands) |
|
Amortization |
Remainder of 2022 |
|
$ |
2,033 |
December 31, 2023 |
|
|
4,067 |
December 31, 2024 |
|
|
4,068 |
December 31, 2025 |
|
|
4,067 |
December 31, 2026 |
|
|
2,855 |
Thereafter |
|
|
8,408 |
Subtotal |
|
$ |
25,498 |
Asset not yet placed in service |
|
|
3,942 |
Total |
|
$ |
29,440 |
|